Vineland Adaptive Behaviour Scales II - Survey Interview form

COA At-a-Glance

Evidence of cognitive interviewing of draft instrument in target patient population

Evidence of internal consistency

Evidence of test-retest or inter-rater reliability

Evidence of concurrent validity

Evidence of known-groups validity

Evidence of ability to detect change over time

Evidence of responder thresholds

Inclusion of the COA in product labelling

Communication/Language
Daily function

Overview

Instrument Name: Vineland Adaptive Behaviour Scales II - Survey Interview form

Abbreviation: Vineland II - Survey Interview form

Description of Tool:

The Vineland Adaptive Behaviour Scales II - Survey Interview form is an ObsRO developed to assess personal and social skills used by an individual or child aged 0-90 years in daily situations. Especially suitable for assessing those with mental retardation or who have difficulty performing in testing situations.

Other Related Tools (if applicable):

Vineland III Comprehensive Interview Form - Vineland Adaptive Behaviour Scales - Third Edition Comprehensive Interview Form
Vineland III Domain-Level Interview Form - Vineland Adaptive Behaviour Scales - Third Edition Domain-Level Interview Form
Vineland III Comprehensive Parent/Caregiver Form - Vineland Adaptive Behaviour Scales - Third Edition Comprehensive Parent/Caregiver Form
Vineland III Domain-Level Parent/Caregiver Form - Vineland Adaptive Behaviour Scales - Third Edition Domain-Level Parent/Caregiver Form
Vineland III Comprehensive Teacher Form - Vineland Adaptive Behaviour Scales - Third Edition Comprehensive Teacher Form
Vineland III Domain-Level Teacher Form - Vineland Adaptive Behaviour Scales - Third Edition Domain-Level Teacher Form
Vineland Adaptive Behavior Scales - Third Edition Maladaptive Behavior Domain Comprehensive Interview Form
Vineland Adaptive Behavior Scales – Third Edition Maladaptive Behavior Domain Comprehensive Parent/Caregiver Form
Vineland Adaptive Behavior Scales – Third Edition Maladaptive Behavior Domain Domain-Level Interview Form
Vineland Adaptive Behavior Scales – Third Edition Maladaptive Behavior Domain Domain-Level Parent/Caregiver Form
Vineland II - Expanded Interview form - Vineland Adaptive Behaviour Scales II - Expanded Interview form
Vineland II - Parent/Caregiver form - Vineland Adaptive Behaviour Scales II - Parent/Caregiver form
Vineland II - Teacher Rating form - Vineland Adaptive Behaviour Scales II - Teacher Rating form

Minimum Qualification Required by COA Administrator: MA or BA

Comment:

Published in 1984, revised in 2005

Expanded Interview, Parent/Caregiver and Teacher Rating forms were also developed

Year: 2005

Objective of Development:

To assess personal and social skills used by an individual or child in daily situations. Especially suitable for assessing those with mental retardation or who have difficulty performing in testing situations.

Population of Development: Age range (therapeutic indication):

0-90 years (Generic for Psychiatry Psychology)

Pediatric Population(s) in which COA has been used:

Vineland II: Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases; Mental Disorders; Neoplasms; Nutritional and Metabolic Diseases; Male Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Cardiovascular Diseases; Endocrine System Diseases; Wounds and Injuries; Skin and Connective Tissue Diseases; Hemic and Lymphatic Diseases; Virus Diseases; Digestive System Diseases; Musculoskeletal Diseases; Otorhinolaryngologic Diseases

COA type:

Number of Items 433 items

Mode of Administration:

Data Collection Mode:

Time for Completion: 20-60 min

Response Scales: 3-point Likert/Likert-type Scale ranging from 0 "Never" to 2 "Usually"

Summary of Scoring:

Available Scores:
- Scores by domains

Weighting:
- No

Score Direction:
No information


Content Validity

Evidence of Literature Review: None identified

Evidence of Instrument Review: None identified

Evidence of Clinical or Expert Input: None identified

Evidence of concept elicitation in target patient population: None identified

Evidence of a Saturation Grid: None identified

Evidence for Selection of Data Collection Method: None identified

Recall/Observation Period:

Evidence for Selection of Reponse Options: None identified

Evidence of cognitive interviewing of draft instrument in target patient population: None identified

Evidence of Preliminary Scoring of Items and Domains: None identified

Evidence related to respondent and administrator burden: None identified

Evidence of a Conceptual Framework: None identified

Evidence of an item-tracking matrix: None identified

Evidence related to item selection: None identified

Evidence of re-testing the final version: None identified


Reliability

Internal consistency (Cronbach's alpha): None identified

Evidence of internal consistency:

Test-retest Reliability (ICC):

None identified

Inter-rater/ inter-interviewer reliability (kappa):

None identified

Evidence of test-retest or inter-rater reliability: None identified


Validity

Concurrent validity (convergent, divergent):

None identified

Known-group validity:

Ekstrom AB (2009)
Measure/Groups of patients: Correlation between VABS-II without motor domain and Full Scale Intelligence Quotient (FSIQ) determined with Griffiths Developmental Scale, Wechsler Primary and Preschool Scale of Intelligence-Revised, Wechsler Intelligence Scale for Children or Wechsler Adult Intelligence Scale in patients with myotonic dystrophy type 1 (DM1) classified into categories: congenital DM1 (= 19), mild congenital DMA (n= 18) and childhood DM1 (n= 18)
A priori hypotheses: Not stated
Were hypotheses confirmed: Not applicable
Results: Spearman's coefficient correlation
- Significant (p< 0.01) correlation was found between FSIQ and VABS-II in the mild congenital DM1 group: r= 0.95 - Significant (p< 0.01) correlation was found between FSIQ and VABS-II in the childhood DM1: r= 0.92 Population/Disease: Patients with DM1; n= 55 Severe congenital DM1 (n= 19, mean age year:month (SD)= 10:7 (6:1) Mild congenital DM1 (n= 18, mean age year: month (SD)= 11:11 (4:5) Childhood DM1 (n= 18, mean age year: month (SD)= 13:8 (4:2)

Evidence of Translatability Assessment: None identified

Evidence related to missing data: No information

Evidence for Selection of Recall Period: None identified

Evidence of Administration Instructions and Training Provided: Yes

Evidence of concurrent validity: None identified

Evidence of known-groups validity: Yes

Evidence of ability to detect change over time: None identified


Ability to Detect Change

Ability to detect change (Responsiveness):

None identified


Responder Thresholds

Responder Thresholds:

None identified

Evidence of responder thresholds: None identified


Reference(s) of development / validation

Pearson’s Clinical Assessment group. Vineland Adaptive Behavior Scales | Third Edition [Internet].Bloomington, USA: Pearson; Consulted on March 23rd. Available from: https://www.pearsonassessments.com/store/usassessments/en/Store/Professional-Assessments/Behavior/Adaptive/Vineland-Adaptive-Behavior-Scales-%7C-Third-Edition/p/100001622.html?tab=resources

Other references:
EKSTRÖM, ANNE‐BERIT, et al. "Cognition and adaptive skills in myotonic dystrophy type 1: a study of 55 individuals with congenital and childhood forms." Developmental Medicine & Child Neurology 51.12 (2009): 982-990. (https://onlinelibrary.wiley.com/doi/full/10.1111/j.1469-8749.2009.03300.x)

Fisch, Gene S., et al. "The course of cognitive‐behavioral development in children with the FMR1 mutation, Williams–Beuren syndrome, and neurofibromatosis type 1: The effect of gender." American Journal of Medical Genetics Part A 152.6 (2010): 1498-1509. (https://onlinelibrary.wiley.com/doi/full/10.1002/ajmg.a.33412)

Truxal, K. V., et al. "A prospective one-year natural history study of mucopolysaccharidosis types IIIA and IIIB: Implications for clinical trial design." Molecular genetics and metabolism 119.3 (2016): 239-248.

Bennett, Jeffrey A., et al. "Investigating autism-related symptoms in children with Prader-Willi syndrome: A case study." International journal of molecular sciences 18.3 (2017): 517. (https://www.mdpi.com/1422-0067/18/3/517)


Other references

Farmer C, Adedipe D, Bal VH, Chlebowski C, Thurm A. Concordance of the Vineland Adaptive Behavior Scales, second and third editions. J Intellect Disabil Res. 2020 Jan;64(1):18-26. doi: 10.1111/jir.12691. Epub 2019 Oct 28. PMID: 31657503; PMCID: PMC6941197.


Inclusion of the COA in product labelling

None identified


Existence of Scoring / Interpretation / User Manual


Original language and translations

Original language: English

Translations:
*Cebuano for the Philippines
 *Danish for Denmark
 *Dutch for Belgium (Flemish)
 *Dutch for the Netherlands
 *English for Australia
 *English for Canada
* English for South Africa
 *English for the UK
*French for Belgium
 *French for Canada
 *German for Germany
 *Greek for Greece
 *Hebrew for Israel
 *Japanese for Japan
 *Korean for South Korea
 *Norwegian for Norway
 *Polish for Poland
 *Portuguese for Portugal
 *Spanish for Argentina
 *Spanish for Colombia
*Spanish for Mexico
 *Spanish for the USA
 *Tagalog for the Philippines
 *Turkish for Turkey


References of translations

None identified


Authors and contact information

Contact information
Pearson Assessment
19500 Bulverde Rd
San Antonio, TX 78259-3701
USA

Elizabeth Werner and Dr. Paul Williams from Pearson Research Services
E-mail: research.licensing@pearson.com


Website

https://www.pearsonassessments.com/


Review copy

Please contact Pearson Assessment, Inc